CEMATRIX Corporation Announces Letter of Intent for

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
35
CEMATRIX Corporation Announces Letter of Intent for Proposed Acquisition of Pacific International Grout Company and the Engagement of Joseph Gunner and Co. LLC as an Exclusive Investment Banker

CALGARY, Alberta, Jan. 21, 2019 (GLOBE NEWSWIRE) -- CEMATRIX Corporation (TSXV: CVX) (the “ Corporation ” or “ CEMATRIX ”) is pleased to announce that it has entered into a letter of intent with Pacific International Grout Co. (“ PIGCO ”) dated January 18, 2019 (the “ Letter of Intent ”) in respect of a proposed transaction pursuant to which all of the issued and outstanding shares of PIGCO (the “ PIGCO Shares ”) will be acquired either directly by CEMATRIX or through a subsidiary, such that  PIGCO will be, directly or indirectly, a wholly owned subsidiary of CEMATRIX (the “ Acquisition ”). It is currently anticipated that the Acquisition will occur as a share sale, with the final structure of the Acquisition being subject to receipt of tax, corporate and securities law advice for both CEMATRIX and PIGCO. Upon completion of the Acquisition, PIGCO, or such other appropriate US entity the Purchaser uses to acquire the PIGCO Shares and continue the operations of PIGCO (the “ Operational Subsidiary ”), will continue to carry on the business of PIGCO.

“PIGCO is a profitable leading west provider of cellular concrete and engineered grouts in the United States and Canada, and it has completed successful projects across the United States and internationally, as well,” stated Jeff Kendrick, President and Chief Executive Officer of CEMATRIX. “PIGCO, through its founder Patrick Stephens, is recognized as an expert in difficult and problematic projects.  CEMATRIX believes that the acquisition of PIGCO will confirm CEMATRIX as the foremost source of cellular concrete throughout North America.  Most important to CEMATRIX as well, is that upon closing of the Acquisition, the owner of all of the PIGCO Shares, Mr. Patrick Stephens (the “ Vendor ”), will be a significant shareholder of CEMATRIX and Mr. Stephens has also agreed to provide sales, technical and operational support for PIGCO and CEMATRIX for a minimum of three and up to five years, or more, following the closing of the Acquisition.”

In addition to the increased sales, profits and cash flows that PIGCO will bring to CEMATRIX (it is estimated that PIGCO currently has over $17 million USD in projects contracted to be completed over the next three years, mainly late 2019 and 2020), PIGCO also owns certain technologies and equipment that management believes could allow CEMATRIX to enter into markets that it currently does not pursue.

General Information on PIGCO

PIGCO is an S Corporation incorporated under the laws of Washington, with a head office in Bellingham, Washington. PIGCO is a contractor in the same business as CEMATRIX specializing in low density foam concrete, engineered grouts and cement-based materials, as well as offering complete installation services including technical mix design support and development for a wide variety of construction applications in the United States and Canada.

PIGCO specializes in production and placement of cellular concrete and engineered slurries for heavy construction, mining and hazardous material encapsulation including Nuclear Decommissioning. Over the years PIGCO had developed and been granted 19 U.S. and 12 International patents for method and process apparatus for the cellular concrete industry and mining.  These patents have expired but the technology is still practiced by PIGCO.

PIGCO also manufactures the proprietary equipment that they use to mix and place cellular concrete and have vast experience and knowledge having completed over 1.6 million feet of pipe in tunnel and underground casings. 

The Acquisition

Pursuant to the Letter of Intent, consideration for the PIGCO Shares shall be paid to the Vendor by CEMATRIX as follows:

  • $500,000 (USD) in common shares of CEMATRIX (the “ CEMATRIX Shares ”);
  • cash in the amount of $3,250,000 (USD), which includes a minimum of $250,000 (USD) in deemed working capital to continue operations as supported by an appraisal of capital equipment; and
  • $3,500,000 (USD) by way of earn-out payment (the “ Earn-out ”) calculated on the operations of Operational Subsidiary for up to four years following closing of the Acquisition. The Earn-out will pay the Vendor a percentage of PIGCO’s EBITDA in excess of $500,000 (USD) for a period of up to four years, the percentage of which will be determined and agreed to during the due diligence process.

Appointment of Joseph Gunnar & Co.

The Corporation is pleased to announce that effective January 1, 2019, it has entered into an exclusive agreement with a Wall Street investment banking and securities boutique, Joseph Gunnar & Co. LLC. This investment bank will be providing CEMATRIX with financial advisory services, in particular relating to evaluating financing options and targeting further U.S. based acquisitions including the PIGCO acquisition.

Additionally, Joseph Gunnar & Co. LLC will also focus on assisting CEMATRIX in creating and executing new strategies for maximizing shareholder value, through its full scope of investment  banking  services. The Corporation does not have a defined timeline for any specific financing and cannot provide any assurance whether or when a financing will be announced or consummated.

"We see a great deal of growth opportunity focusing on the lucrative and growing U.S. infrastructure market and are pleased to have engaged Joseph Gunnar & Co. LLC as the Corporation's exclusive investment bank,” stated Jeff Kendrick, CEO of CEMATRIX. “Joseph Gunnar has a long history of assisting public companies raise additional growth capital. It is of the upmost importance that we have a strong balance sheet and a financing, if consummated will allow CEMATRIX to significantly accelerate its growth plans."

Proposed Financing

The Letter of Intent contains a condition that CEMATRIX obtain sufficient financing to complete the Acquisition and maintain sufficient working capital after closing of the Acquisition in its sole discretion. Such financing is anticipated to come from a combination of debt and equity, which will be finalized during the acquisition process and guided by Joseph Gunnar & Co.

Additional Information

The Acquisition will be carried out by parties dealing at arm’s length to one another and therefore will not be considered to be a “Non-Arm’s Length Transaction”, as such term is defined under the policies of the Exchange, however, the Acquisition will constitute a “Fundamental Acquisition” under the policies of the Exchange. No finder’s fees are payable by CEMATRIX as a part of the Acquisition.

The Letter of Intent is expected to be superseded by a definitive agreement (the “ Definitive Agreement ”) to be signed between the parties (which agreement shall include representations, warranties, conditions and covenants typical for a transaction of this nature). The Acquisition is subject to the receipt of all necessary regulatory, corporate and third party approvals, including the approval of the Exchange, and the satisfaction of customary closing conditions: including the approval of the Definitive Agreement and the Acquisition by the board directors of CEMATRIX; completion of due diligence investigations to the satisfaction of CEMATRIX; the arranging of appropriate financing by CEMATRIX for the Acquisition; PIGCO retaining a minimum deemed working capital at closing, to be agreed to during or after the due diligence process; compliance with all applicable regulatory requirements and conditions in connection with the Acquisition; the absence of any material adverse condition with respect to the financial and operational condition or the assets of PIGCO; and the delivery of customary closing documentation.

CEMATRIX is an Alberta corporation with its head offices in Calgary, Alberta. The Corporation, through its wholly owned Canadian and US subsidiaries, is a rapidly growing company that manufactures and supplies technologically advanced cellular concrete products developed from proprietary formulations. This unique cement-based material with superior thermal protection, delivers a cost-effective, innovative solution to a broad range of problems facing the infrastructure, industrial (including oil and gas) and commercial markets. The Corporation is a reporting issuer in the provinces of British Columbia and Alberta.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information, please contact:

Jeff Kendrick - President and Chief Executive Officer Phone: (403) 219-0484

Jeff Walker, The Howard Group – Investor Relations Phone: (888) 221-0915 or (403) 221-0915 jeff@howardgroupinc.com

This news release contains forward-looking information within the meaning of applicable securities laws relating to the proposal to complete the Acquisition and associated transactions, including statements regarding the terms and conditions of the Acquisition. The information about PIGCO contained in the press release has not been independently verified by the Corporation. Although the Corporation believes in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Corporation can give no assurance that they will prove to be correct. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements depending on, among other things, the risks that the parties will not proceed with the Acquisition and associated transactions will differ from those that currently are contemplated, and that the Acquisition and associated transactions will not be successfully completed for any reason (including the failure to obtain the required approvals or clearances from regulatory authorities). The terms and conditions of the Acquisition may change based on the Corporation’s due diligence and the receipt of tax, corporate and securities law advice for both CEMATRIX and PIGCO. The statements in this press release are made as of the date of this release. The Corporation undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Corporation, PIGCO, their securities, or their respective financial or operating results (as applicable).

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

ING's Successful Share Buyback and New €1.6 Billion Plan

Updated Category News Views 246

ING Finalizes Share Buyback and Unveils New Distribution Strategy Recently, ING announced that it has successfully completed its comprehensive share buyback program. This initiative, which commenced earlier, concluded with the repurchase of an impressive total of 101,193,469 ordinary shares at an average price of €19.77, resulting in a total expenditure of approximately...

Continue Reading
Aicuris' Pritelivir Shows Promise for Immunocompromised Patients

Updated Category News Views 203

Breakthrough Results for Pritelivir in Immunocompromised Patients Pritelivir has distinguished itself in the realm of treatment for refractory Herpes Simplex Virus (HSV) infections among immunocompromised patients. The recent Phase 3 trial reported a statistically significant superiority in lesion healing compared to standard-of-care treatments, demonstrating the...

Continue Reading
Market Insights: Bitcoin's Stability Amidst Altcoin Declines

Updated Category News Views 213

Market Dynamics: Bitcoin Stands Firm as Altcoins Dwindle In a recent turn of events, leading altcoins such as Ethereum and XRP experienced significant price drops, indicating a potential shift in the cryptocurrency market's dynamics. This selloff occurred after a period of robust growth within the broader market, shaking investor confidence. Understanding the Market...

Continue Reading
American Rebel Holdings Partners with Ace Distributing in PA

Updated Category News Views 164

American Rebel Holdings Strengthens Beer Distribution Network Ace Distributing, a prestigious beer wholesaler with a rich history, has joined the American Rebel Light Beer family. This partnership marks a significant step in American Rebel's strategy to enhance its distribution network across Pennsylvania. The Partnership Breakdown American Rebel Holdings, Inc. (NASDAQ:...

Continue Reading
Core Natural Resources Delivers Strong Q3 Performance Insights

Updated Category News Views 143

Core Natural Resources Achieves Impressive Q3 Results Core Natural Resources, Inc. (NYSE: CNR) has just reported an exciting fiscal performance for its third quarter, showcasing substantial growth in net cash generated from operating activities and increased shareholder returns. Strong Financial Milestones The company generated net cash provided by operating activities...

Continue Reading